beta-lactams has been researched along with clarithromycin in 21 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (clarithromycin) | Trials (clarithromycin) | Recent Studies (post-2010) (clarithromycin) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 7,149 | 1,606 | 2,504 |
| Protein | Taxonomy | beta-lactams (IC50) | clarithromycin (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 5.5 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3113 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.0903 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 6 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, T; Hasegawa, M; Igari, J; Kobayashi, I; Matsuzaki, K; Nasu, M; Saika, T; Saionji, K | 1 |
| Matsuda, K; Matsumoto, S; Matsumoto, Y; Sasaki, H; Takasugi, H; Yoshida, Y | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Fujikawa, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Mitsuno, Y; Yoshida, H | 1 |
| Amitani, R; Kimoto, T; Suzuki, K; Tanaka, E; Tsuyuguchi, K | 1 |
| Peetermans, WE; Van Kerkhoven, D; Verbist, L; Verhaegen, J | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Buxbaum, A; Gattringer, R; Georgopoulos, A; Graninger, W; Lagler, H; Sauermann, R; Stich, K | 1 |
| Kobayashi, C; Sakai, T; Shinohara, M | 1 |
| Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
| Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N | 1 |
| Carbonnelle, S; De Bel, A; Dediste, A; Glupczynski, Y; Huang, TD; Jacobs, F; Jordens, P; Lismond, A; Schatt, P; Tulkens, PM; Van Bambeke, F; Verhaegen, J; Verschuren, F | 1 |
| Arnold, C; Bassetti, S; Piso, RJ | 1 |
| Kishimoto, K; Matsuse, H; Nakayama, H; Oshio, T | 1 |
| Adami, ME; Alexiou, N; Giamarellos-Bourboulis, EJ; Gogos, C; Halvatzis, S; Kosmas, V; Koutoukas, P; Kyprianou, A; Kyprianou, M; Kyriakoudi, A; Kyriazopoulou, E; Lada, M; Makina, A; Niederman, MS; Pavlaki, M; Sinapidis, D; Stefos, A; Velissaris, D | 1 |
| Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y | 1 |
| Guler, N; Hizli Demirkale, Z; Ozdemir, C; Sipahi Cimen, S; Suleyman, A; Tamay, ZU; Yucel, E | 1 |
| Al-Salloum, J; Gillani, SW; Gulam, SM; Mahmood, RK | 1 |
| Aydiner, C; Ikizoglu, B; Kanat, G; Turkdogan, FI | 1 |
| Karpova, OY; Pigusova, NA; Rachina, SA; Sinopalnikov, AI; Vasilyeva, IS | 1 |
1 review(s) available for beta-lactams and clarithromycin
| Article | Year |
|---|---|
Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Community-Acquired Infections; Humans; Pneumonia, Bacterial | 2021 |
1 trial(s) available for beta-lactams and clarithromycin
| Article | Year |
|---|---|
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
19 other study(ies) available for beta-lactams and clarithromycin
| Article | Year |
|---|---|
[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates].
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Resistance, Microbial; Helicobacter pylori; Humans; Lactams | 1998 |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clarithromycin; Disease Models, Animal; Helicobacter pylori; Lactams; Mice; Molecular Structure | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Bronchopneumonia; Clarithromycin; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome | 2001 |
Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection.
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Humans; Lactams; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous | 2002 |
Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Retrospective Studies; Treatment Failure | 2003 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Topics: Anti-Bacterial Agents; Austria; Azithromycin; Bacterial Proteins; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Hungary; Josamycin; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Pharyngitis; Pharynx; Skin; Streptococcal Infections; Streptococcus pyogenes; Tetracycline Resistance; Tonsillitis; Vagina | 2004 |
Mycobacterium peregrinum infection in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; Humans; Imipenem; Lactams; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; RNA, Viral | 2005 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
Levofloxacin-induced delirium.
Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment | 2009 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; beta-Lactams; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Vaccination; Young Adult | 2012 |
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index | 2013 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION THAT DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY FOR MYASTHENIA GRAVIS WITH RECURRENT THYMOMA].
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Myasthenia Gravis; Mycobacterium Infections, Nontuberculous; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome | 2016 |
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clarithromycin; Cohort Studies; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2020 |
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex.
Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA | 2020 |
Clarithromycin hypersensitivity in children: Is there a link with β-lactam hypersensitivity?
Topics: Anti-Bacterial Agents; beta-Lactams; Child; Clarithromycin; Drug Hypersensitivity; Humans; Skin Tests | 2021 |
Seasonal analysis of commonly prescribed antibiotics in Istanbul city.
Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Seasons; Sewage; Solid Phase Extraction; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2023 |
[Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Clarithromycin; Community-Acquired Infections; Female; Humans; Interleukin-6; Male; Middle Aged; Pneumonia; Tumor Necrosis Factor-alpha; Young Adult | 2023 |